PARNAX LAB
|
The Current P/E Ratio of PARNAX LAB is 14.39.
| Share Price | ₹147.6 | Jul 16,2026 |
| Market Cap | ₹169.7 Cr | |
| Earnings-TTM | ₹11.8 Cr | TTM-Consolidated Results |
| Price/Earnings | 14.39x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of PARNAX LAB
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹169.7 Cr] as on Jul 16,2026
(/) Earnings [ ₹11.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 14.39x ]
Thus, for PARNAX LAB , the investors are currently willing to pay 14.39 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PARNAX LAB !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PARNAX LAB over the last five years.
Historical PE (Price/Earnings) ratio chart of PARNAX LAB
PE Ratio Performance Analysis for PARNAX LAB
- PARNAX LAB 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 9.75x.
- PARNAX LAB 's operated at median p/e ratio of 10.67x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PARNAX LAB 's p/e ratio peaked in Mar2022 at 15.68x.
- PARNAX LAB 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does PARNAX LAB 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| PARNAX LAB | 11.80 | 14.39 | 169.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 40.46 | 467,870.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 75.67 | 194,316.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 79.19 | 169,316.0 |
| CIPLA LTD | 3,869.79 | 29.84 | 115,477.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 24.65 | 102,156.0 |
| MANKIND PHARMA LTD | 1,926.41 | 54.56 | 105,107.0 |
| LUPIN LTD | 5,355.47 | 21.34 | 114,311.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.89 | 115,062.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 25.44 | 89,074.2 |
| LAURUS LABS LTD | 889.85 | 94.57 | 84,149.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PARNAX LAB 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 14.39x |
| Max industry PE | 94.57x |
| Median industry PE | 29.84x |
| Average industry PE | 43.91x |
You may also like the below Video Courses